Literature DB >> 25443454

Prevalence of prediabetes in patients with acute coronary syndrome: impact on in-hospital outcomes.

M M AbuShady1, Y Mohamady, B Enany, W Nammas.   

Abstract

BACKGROUND: Prediabetes is a serious condition that is associated with an increase in cardiovascular morbidity and mortality. AIMS: We sought to explore the prevalence of prediabetes in patients admitted with acute coronary syndrome (ACS) who were not known to have diabetes and to determine the impact of prediabetes on in-hospital clinical outcomes versus non-diabetic patients.
METHODS: Prospectively, we enrolled 200 patients not known to have diabetes or prediabetes, admitted with ACS. Laboratory tests included fasting plasma glucose (FPG), 2-h plasma glucose (2hPG) after 75 g glucose, HbA1c and lipid profile. Electrocardiogram and echocardiography were done. The primary end-point was in-hospital major adverse cardiovascular events (MACE).
RESULTS: Mean age was 50.9 ± 6.8 years (70.5% males). The prevalence of patients with diabetes and patients with prediabetes was 24.5% and 20% respectively. Newly discovered diabetic patients were excluded. Compared with patients without diabetes, prediabetic patients had a higher body mass index (BMI) (P = 0.002) and a longer hospital stay (P = 0.09). In-hospital MACE occurred in 10 (25%) patients with prediabetes versus six (5.4%) in patients without diabetes (P = 0.001). In-hospital MACE correlated with prediabetes (r = 0.28, P < 0.001), BMI (r = 0.14, P = 0.093), FPG (r = 0.19, P = 0.014), 2hPG (r = 0.19, P = 0.017) and HbA1c (r = 0.19, P = 0.019). Multivariate regression analysis identified prediabetes as the only independent predictor of in-hospital MACE.
CONCLUSIONS: Prediabetes is common in patients presenting with ACS who are not previously known to have diabetes. Prediabetic patients had worse in-hospital clinical outcomes compared with patients without diabetes.
© 2014 Royal Australasian College of Physicians.

Entities:  

Keywords:  acute coronary syndrome; major adverse cardiovascular event; outcome; prediabetes; prevalence

Mesh:

Substances:

Year:  2015        PMID: 25443454     DOI: 10.1111/imj.12651

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  3 in total

1.  HbA1c screening for new onset diabetes following acute coronary syndrome: is it a worthwhile test in clinical practice?

Authors:  Sebastian T Lugg; Christine J H May; Peter Nightingale; Robbie P E Tuffley; June Al-Hourani; Parijat De
Journal:  J Diabetes Metab Disord       Date:  2017-04-04

2.  Glucose tolerance and markers of myocardial injury after an acute coronary syndrome: predictive role of the 1-h plus 2-h plasma glucose at the oral glucose tolerance test.

Authors:  Viola Zywicki; Paola Capozza; Paolo Caravelli; Stefano Del Prato; Raffaele De Caterina
Journal:  Cardiovasc Diabetol       Date:  2022-08-08       Impact factor: 8.949

3.  Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis.

Authors:  Wenjun Pan; Haining Lu; Baotao Lian; Pengda Liao; Liheng Guo; Minzhou Zhang
Journal:  Cardiovasc Diabetol       Date:  2019-12-11       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.